Arovella Therapeutics Ltd has released a press release.
SPP Offer Booklet
Filed with ASX ·
On 6ix: 6ix.com/news/spp-offer-booklet-1
6ix hasn’t read this filing yet.
Arovella Therapeutics Limited on 6ix
Earlier from Arovella Therapeutics
- AGM FY21 Presentation
- Arovella licences novel monoclonal antibody from MD Anderson
- Chile Ministry of Health Approval Granted for ZolpiMist
- GM presentation
- Dr Reuben Benjamin Appointed to SUDA iNKT Cell Therapy SAB
Later from Arovella Therapeutics
- Investor Presentation
- Arovella SPP Closed early over subscribed
- Update - Proposed issue of securities - ALA
- Application for quotation of securities - ALA
- Arovella Therapeutics: Proposed issue of securities - ALA
Follow Arovella Therapeutics into a list and get an email when it puts out news.
Follow Arovella Therapeutics